We recently had the opportunity to interview Michelle Warner, Global Medical Affairs Leader at GlaxoSmithKline. Michelle is a champion of being KOL-Centric, always keeping the team focused on the needs and interests of the KOL in their scientific relationships and...
Recently, several Medical Affairs organizations reached out with the same concern. Their Medical Directors wanted to improve their Key Opinion Leader (KOL) engagement outcomes but were not sure how to revise their engagement plans to make that happen. We’ll...
